D. De Totero et al., IL4 production and increased CD30 expression by a unique CD8(+) T-cell subset in B-cell chronic lymphocytic leukaemia, BR J HAEM, 104(3), 1999, pp. 589-599
Phenotypic and functional abnormalities within the residual non-B-cell comp
artment of B-cell chronic lymphocytic leukaemia (CLL) suggest an interactio
n between tumour cells and host immune effecters. To explore the possibilit
y of a polarized Th1/Th2 response we have studied CD30 antigen expression a
nd the pattern of cytokine production by purified CLL T cells, Activated T
cells from CLL patients showed a significant increase in the expression of
CD30 compared to normal controls. Accordingly, high levels of soluble CD30
were detected in supernatants from activated T-cell cultures, as well as in
CLL serum samples. Messenger RNA for IL4 was found in both resting and, to
a greater extent, in activated CLL T lymphocytes. The latter cells were al
so capable of releasing IL4. Three-colour immunofluorescence analyses revea
led a strong CD30 expression in the CD3(+)/CD8(+)/CD28(-) large granular ly
mphocyte subset, which is considerably expanded in CLL. Production of IL4,
as well as expression and release of CD30 by these T cells, was conclusivel
y demonstrated at the clonal level. These findings document an expansion of
a peculiar subset of 'Th2-like' cells in CLL. with an increased IL4 produc
tion and CD30 expression and release, that are likely to contribute to both
the B-cell accumulation and immune-defects characteristic of this disease.